Abstract
Hemicrania Continua (HC) is a strictly unilateral continuous headache that is exquisitely responsive to Indometacin but some patients cannot tolerate this drug. Evidence for other therapies is limited, often limited to single case reports.
Highlights
Hemicrania Continua (HC) is a strictly unilateral continuous headache that is exquisitely responsive to Indometacin but some patients cannot tolerate this drug
Previous case reports on its use in HC are limited to two patients
We present outcome data on eight patients with HC treated with BoNT-A
Summary
Hemicrania Continua (HC) is a strictly unilateral continuous headache that is exquisitely responsive to Indometacin but some patients cannot tolerate this drug. Evidence for other therapies is limited, often limited to single case reports. Aim Onabotulinum Toxin A (BoNT-A) is licensed for use in chronic migraine. Previous case reports on its use in HC are limited to two patients. We present outcome data on eight patients with HC treated with BoNT-A
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
